RECRUITING

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

Official Title

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

Quick Facts

Study Start:2024-02-09
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06370780

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have access to a personal smartphone device;
  2. * Over 18 years of age;
  3. * Speak English or Spanish;
  4. * Living with HIV
  5. * Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
  6. * Active substance use or mental health disorder;
  7. * Willing and able to provide written informed consent to take part in the study.
  1. * Unwilling or unable to provide reliable contact information;
  2. * Unwilling to provide blood sample for HIV virology testing;
  3. * Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.

Contacts and Locations

Study Contact

Pamina Gorbach, DrPh
CONTACT
(628) 226-1863
RemainApp@ph.ucla.edu
Valerie El-Alfi, MA
CONTACT
RemainApp@ph.ucla.edu

Principal Investigator

Pamina Gorbach, DrPh
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles

Study Locations (Sites)

University of California, Los Angeles
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Pamina Gorbach, DrPh, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-09
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2024-02-09
Study Completion Date2025-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • HIV Infections